Estrella Immunopharma Inc... (ESLA)
NASDAQ: ESLA
· Real-Time Price · USD
0.91
0.05 (5.76%)
At close: Aug 15, 2025, 3:59 PM
0.89
-1.70%
After-hours: Aug 15, 2025, 04:12 PM EDT
Estrella Immunopharma Ratios and Metrics
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Feb 28, 2021 |
PE Ratio | -1.57 | -3.99 | -10.48 | -3.11 | -2.55 | -23.83 | -9.57 | -1.31 | -83.08 | -97.32 | -2.17 | -42.66 | -81.93 | -86.81 | -823.58 | -134.62 | -4.16K | n/a |
PEG Ratio | -0.01 | -0.04 | 0.15 | 0.20 | -0.00 | 0.44 | 0.10 | -0.00 | -4.18 | 1.00 | -0.00 | -0.46 | -13.88 | -0.1 | 9.84 | -0.05 | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -5.7 | -18.32 | 306.25 | 56.28 | 9.42 | 5.27 | 4.32 | 0.98 | 3.64 | 3.52 | -3.7 | 1.36 | 8.06 | 1.33 | 7.90 | 1.31 | 2.87K | n/a |
P/FCF Ratio | -83.68 | -71.99 | -49.12 | -18.94 | -138.15 | -10.57 | -3.47 | -35.73 | -118.76 | -89.4 | -221.59 | -114.68 | -379.87 | -544.59 | -1.19K | -3.62K | -9.77K | n/a |
P/OCF Ratio | -83.68 | -71.99 | -49.12 | -18.94 | -138.15 | -10.57 | -3.47 | -35.73 | -118.76 | -89.4 | -221.59 | -114.68 | -379.87 | -544.59 | -1.19K | -3.62K | -9.77K | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.03 | 0.13 | 0.10 | -0.01 | 0.01 | n/a | n/a | n/a | n/a | 8.73 | 4.14 |
Quick Ratio | 0.16 | 0.22 | 0.55 | 0.75 | 24.65 | 65.27 | 23.69 | 1.58 | 0.09 | 0.07 | 0.64 | 0.22 | 0.83 | 14.18 | 8.42 | 7.75 | 0.06 | 0.19 |
Current Ratio | 0.16 | 0.22 | 0.55 | 0.75 | 24.65 | 62.34 | 23.69 | 1.58 | 0.09 | 0.07 | 0.64 | 0.22 | 0.83 | 14.18 | 8.42 | 7.75 | 0.06 | 0.19 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 0.91 | 1.15 | -7.31 | -4.52 | -0.92 | -0.06 | -0.11 | -0.19 | -0.01 | -0.01 | 0.43 | -0.01 | -0.02 | n/a | n/a | n/a | -0.17 | n/a |
Return on Assets | -1.86 | -0.86 | -0.33 | -0.9 | -0.89 | -0.05 | -0.11 | -0.07 | -0.01 | -0.01 | -0.9 | -0.01 | -0.02 | n/a | n/a | n/a | n/a | n/a |
Return on Invested Capital | 0.91 | 1.15 | -7.31 | -4.52 | -0.92 | -0.06 | -0.11 | -0.18 | -0.02 | -0.02 | 1.95 | -0.01 | -0.02 | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |